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ABSTRACT
Objective: To evaluate the changes in corneal topography indices and corneal thickness after cross-linking treatment for 
keratoconus.
Study Design: Retrospective Observational Study
Patients and Methods: The data of patients who underwent corneal collagen cross-linking treatment for keratoconus were 
retrieved. Central corneal thickness (CCT), maximum and mean keratometry (Kmax, Kmean) values and topography indices: index 
of surface variance (ISV), index of vertical asymmetry (IVA), keratoconus index (KI), central keratoconus index (CKI), minimum 
radius of curvature (Rmin), index of height asymmetry (IHA), and index of height decentration (IHD) were obtained from 
Pentacam and Wavelight-Allegretto Wave Topolyzer outputs. Follow-up was 18 months.
Results: The study comprised of 15 eyes of 10 patients with keratoconus. Central corneal thickness had decreased significantly 
1 month after the procedure (p=0.003) but there were no statistically significant changes between the baseline values and 
last visits (p>0.05). Kmax and Kmean values were not statistically different from the preoperative values and at the last visits 
(p>0.05). Almost all of the corneal topography indices improved significantly after postoperative 6th month (p<0.05).
Conclusion: There were improvements in topography indices during 18-month follow-up period, suggesting that the cornea 
becomes more optically regular and symmetrical after cross-linking.
Keywords: Cornea, corneal topography, keratoconus
KERATOKONUSUN KOLLAJEN ÇAPRAZ BAĞLAMA TEDAVISI SONRASI KORNEA KALINLIĞI VE TOPOGRAFI INDEKSLERI: 18 
AYLIK TAKIP VE LITERATÜR ÖZETI
ÖZET
Amaç: Keratokonusun çapraz bağlama tedavisi sonrası korneal topografi indekslerinde ve kornea kalınlığında görülen değişik-
liklerin değerlendirilmesi.
Çalışma Planı: Retrospektif Gözlemsel Çalışma
Hastalar ve Yöntemler: Keratokonus tedavisi için korneal kollajen çapraz bağlama tedavisi uygulanan hastaların verileri top-
landı. Santral kornea kalınlığı (SKK), maksimum ve ortalama keratometri (Kmax Kort), değerleri ve topografi indeksleri: index of 
surface variance (ISV), index of vertical asymmetry (IVA), keratoconus index (KI), central keratoconus index (CKI), minimum radius 
of curvature (Rmin), index of height asymmetry (IHA) ve index of height decentration (IHD) Pentacam ve Wavelight-Allegretto 
Wave Topolyzer cihazlarının çıktılarından elde edildi. Takip süresi 18 aydı.
Bulgular: Çalışmada keratokonus hastalığı olan 10 hastanın 15 gözü değerlendirildi. Santral kornea kalınlığı ameliyattan 1 ay 
sonra istatistiksel olarak anlamlı şekilde azaldı (p=0,003) fakat son takip değerlerinde ameliyat öncesi değerlere göre istatistiksel 
olarak anlamlı bir fark yoktu (p>0,05). Kmax ve Kort değerleri son kontrollerde ameliyat öncesi değerlere göre istatistiksel olarak 
farklı değildi (p>0,05). Korneal topografi indekslerinin birçoğu ameliyat sonrası 6. aydan sonra istatistiksel olarak anlamlı şekilde 
düzeldi (p<0,05).
Sonuç: On sekiz aylık takip süresinde korneal topografi indekslerinde düzelme saptanmıştır. Böylece çapraz bağlama tedavisi 
sonrası korneanın optik olarak daha düzenli ve simetrik olduğu sonucuna ulaşmak mümkündür.
Anahtar sözcükler: Kornea, kornea topografisi, keratokonus
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was removed with a corneal scarifier. Standard ribofla-
vin 0.1% (Medio-Cross D, Medio-Haus Medizinprodukte 
GmbH) was instilled every 2 minutes for 30 minutes, i. 
e. 15 drops. The corneal penetration of riboflavin was 
checked with a slit-lamp using cobalt filter. After visu-
alizing yellow colored riboflavin in the anterior cham-
ber, the CT was measured with an ultrasonic pachyme-
try (Accutome AccuPach VI Pachymeter, Accutome Inc., 
Malvern, USA). If the corneal thickness was less than 400 
µm, 1 drop of hypotonic riboflavin 0.1% (MedioCross H, 
Medio-Haus Medizinprodukte GmbH) was administered 
every 10 seconds for 2-minute sessions, after which ul-
trasound pachymetry was performed to confirm that the 
stroma was swollen to at least 400 µm. The procedure 
was proceeded by starting 365 nm UVA radiation (UV-X 
system, IROC AG, Zurich, Switzerland) at an irradiance of 
3.0 mW/cm2. By adjusting the aperture, only the un-epi-
thelized cornea was irradiated and the limbal stem cells 
were avoided. During the application of UVA radiation 
standard riboflavin 0.1% instillation every 2 minutes was 
continued. For some of the patients, isotonic riboflavin 
(MedioCross M, Medio-Haus Medizinprodukte GmbH) 
was used in all parts of the procedure. When the 30 min-
utes of radiation treatment was over, the cornea was 
washed thoroughly with BSS. One drop of an antibiotic 
(Exocin®, Alcon Laboratories, Inc., USA) and a bandage 
contact lens (Plano B. C. : 8.6, Night & Day, Ciba Vision, 
USA) were put on the eye. Contact lens was removed af-
ter epithelial healing, typically 4–5 days postoperatively. 
Until the contact lens was removed; treatment regimen 
was moxifloxacin hydrochloride ophthalmic solution 
0.5% (Vigamox®, Allergan Laboratories, Inc., Ireland) 3 
times daily, nepafenac ophthalmic suspension 0.1% 
(Nevanac®, Alcon Laboratories, Inc., USA) 3 times daily 
and artificial tear drops (Refresh®, Allergan Laboratories, 
Inc., USA) every hour. After the contact lens removal 
loteprednol etabonate ophthalmic suspension 0.5% 
(Lotemax®, Bausch & Lomb, Inc., Florida, USA) was used 4 
times daily and artificial tear drops were used as needed. 
Lotemax® was tapered and discontinued during the fol-
lowing 3 weeks.
The objective refraction measurements were taken by 
the Topcon KR 8900 Auto-Kerato-Refractometer (Topcon 
Corporation, Tokyo, Japan), the CCT and the keratom-
etry values were obtained using the Pentacam (Oculus 
Optikgeräte GmbH, Wetzlar, Germany), corneal topog-
raphy indices were obtained by Wavelight-Allegretto 
Wave Topolyzer (WaveLight Technologie, AG, Erlangen, 
Germany). The uncorrected visual acuity (UCVA), best cor-
rected visual acuity (BCVA) before the operation and at 
Keratoconus is a non-inflammatory progressive disorder of the cornea which is characterized by thinning and ectasia. The central or paracentral 
cornea undergoes progressive thinning and bulging, so 
it takes on the shape of a cone. Mild and moderate ca-
ses can be corrected with glasses or contact lenses, but 
the advanced cases of disease can only get benefit from 
either lamellar or penetrating keratoplasty. Cross-linking 
treatment is the first and only therapeutic option that has 
changed the natural course of keratoconus by stopping 
the progression (1).
Cross-linking arrests the progression of keratoconus by in-
ducing the formation of new covalent crosslinks between 
collagen fibrils (2, 3). The improvement of patients’ kerato-
metric values and visual acuities have been demonstrated 
in many studies (4–6). After an initial decrease in corneal 
thickness (CT) after cross-linking, no difference in CT was 
found between the preoperative values and postopera-
tive one-year (6, 7). Also, while some topography indices 
improved, others remained the same after cross-linking in 
different studies (6, 8).
In this retrospective study we aimed to assess the changes 
in corneal topography indices and central corneal thick-
ness (CCT) 18 months after cross-linking treatment for 
keratoconus.
Materials and methods
The medical records of the patients who underwent cross-
linking treatment for keratoconus at Acıbadem Maslak 
Hospital Ophthalmology Clinic between April 1st, 2008 
and August 31st, 2013 were reviewed and 15 eyes of 10 
patients were included in this retrospective study. The 
study protocol was conducted in accordance with the te-
nets of the Declaration of Helsinki. The inclusion criteria 
were; corneal topography pattern consistent with kerato-
conus, no history of corneal scarring or previous surgery, 
having had cross-linking treatment for once during the 
follow up period, no additional corneal surgeries during 
the follow up period, having at least 2 follow up visits do-
cumented during the first year follow up.
Surgical technique and postoperative management
The corneal collagen cross-linking procedure was per-
formed by the same surgeon (CBC) as described be-
low. After topical anesthesia with 0.5% proparacaine 
hydrochloride (Alcaine, Alcon Laboratories, Inc., USA) 
the operative eye was prepared and draped. The spec-
ulum was inserted, and the central 8.0 mm epithelium 
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the final visit; cylindrical refraction, spherical equivalent 
(SEQ), CCT, Kmax and Kmean values and topography in-
dices: ISV, IVA, KI, CKI, Rmin, IHA, and IHD at each visit 
were recorded. The abnormal and pathologic values for 
these indices are presented in Table 1 (9).
Table 1. Abnormal and pathological values for the topography indices 
(Wavelight-Allegretto Wave Topolyzer, WaveLight Technologie, AG, 
Erlangen, Germany).
Index Abnormal Pathological
ISV ≥37 ≥41
IVA ≥0.28 ≥0.32
KI ≥1.07 ≥1.07
CKI ≥1.03 ≥1.03
Rmin <6.71 <6.71
IHA ≥19 >21
IHD ≥0.014 ≥0.016
CKI: central keratoconus index, IHA: index of height asymmetry,  
IHD: index of height decentration, ISV: index of surface variance,  
IVA: index of vertical asymmetry, KI: keratoconus index,  
Rmin: minimum radius of curvature
Statistical analysis
Statistical analysis was performed with the IBM SPSS 
(Statistical Product and Service Solutions, US) Statistics 
Version 20. Demographic and descriptive data were ex-
pressed as mean±SD. Wilcoxon signed ranks test was used 
to analyze the changes in quantitative data between base-
line and the following visits. At 95% confidence interval, a p 
value less than 0.05 was considered statistically significant.
Results
Out of 10 patients included in the study, six patients were 
men and 4 were women. The mean age was 24.4±6.8 
(range: 13–36) years. The patients’ data were classified in 
the following manner: preoperative visit (pre-op), postop-
erative 1st month±15 days visit (1 mo), 3rd month±15 days 
visit (3 mo), 6th month±15 days visit (6 mo), 12th month±2 
months visit (12 mo), 18th month±2 months visit (18 mo).
Mean preoperative UCVA was 0.62±0.40 logMAR (log of 
the minimum angle of resolution), mean preoperative 
BCVA was 0.28±0.29 logMAR. The patients’ final UCVA was 
0.46±0.46 logMAR, final BCVA was 0.20±0.17 logMAR. The 
change between the preoperative and final values was 
significant for UCVA (p=0.046) but it was not for the BCVA 
(p=0.086).
The cylindrical error, SEQ, CCT, Kmax and Kmean values 
over time are presented in Table 2. Cylindrical error didn’t 
change significantly during the follow-up. The change in 
SEQ between preoperative values and postoperative val-
ues was significant only in 12th month visit. CCT has de-
creased significantly after the procedure but there were 
no statistically significant changes between the baseline 
values and 12th or 18th month visits (Figure 1). Kmax and 
Kmean values were not statistically different from the pre-
operative values at the last visits (Table 2, Figure 1). ISV, IVA, 
Rmin and IHD values improved significantly after postop-
erative 6th month and KI, CKI, IHA values improved signifi-
cantly after 12th month visit (Table 3, Figure 2).
Table 2. Postoperative changes in cylindrical error, SEQ, CCT, Kmax and Kmean measurements
Mean±SD
Postoperative
Preop 1mo 3mo 6mo 12mo 18mo
Cylindirical error
(D)
-3,64±2.80
(n=14)
-4,01±2.73
(n=14)
(p=0.719)
-3,45±2.45
(n=10)
(p=1.000)
-2.80±2.43
(n=10)
(p=0.324)
-3,54±2.21
(n=12)
(p=0,284)
-3,33±2.68
(n=6)
(p=0.059)
SEQ
(D)
-5.92±4.10  
(n=14)
-5.77±4.36 (n=14)
(p=0.656)
-5.30±4.83 (n=10)
(p=0.138)
-4,70±4.08 (n=10)
(p=0.074)
-4,89±3.98 (n=12)
(p=0.006)*
-3.66±3.47 (n=6)
(p=0.080)
CCT 
(µm)
485.23±34.19 
(n=13)
442.67±38.29 
(n=12)
(p=0.003)*
442.50±47.44 
(n=10)
(p=0.012)*
472.80±34.86 
(n=10)
(p=0.008)*
480.92±32.74 
(n=12)
(p=0.894)
488.67±25.71 
(n=6)
(p=0.285)
Kmax
(D)
48.42±4.57 
(n=13)
48.41±3.85
(n=12) (p=0.023)*
48.60±4.88
(n=10) (p=0.889)
46.94±3.81
(n=10) (p=0.233)
48.19±4.42
(n=12) (p=0.171)
46.73±2.87
(n=6) (p=0.854)
Kmean
(D)
46.71±3.92
(n=13)
46.64±3.03
(n=12) (p=0.091)
46.86±3.98
(n=10) (p=0.611)
45.64±3.39
(n=10) (p=0.441)
46.55±3.88
(n=12) (p=0.594)
45.46±2.78
(n=6) (p=0.465)
CCT: central corneal thickness, Kmax: maximum keratometry, Kmean: mean keratometry, SEQ: spherical equivalent
*Statistically significant change from preoperative measurements (p<0.05)
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Figure 1. Change in cylindirical error, spherical equivalent (SEQ), central corneal thickness (CCT), and mean and maximum 
keratometry (Kmean, Kmax) values over time.
Table 3. Summary of corneal topography indices.
Mean±SD
Postoperative
Index Preop 
(n=15)
1mo
(n=12)
3mo
(n=8)
6mo 
(n=9)
12mo
(n=12)
18mo
(n=6)
ISV 
(-) 72.20±39.39
67.41±35.62
(p=0.169)
78.75±40.87
(p=0.553)
65.11±44.73
(p=0.020)*
64.33±26.55
(p=0.002)*
67.00±48.55
(p=0.027)*
IVA (mm) 0.78±0.50 0.67±0.39(p=0.929)
0.82±0.48
(p=0.889)
0.70±0.56
(p=0.015)*
0.65±0.33
(p=0.003)*
0.77±0.62
(p=0,042)*
KI
(-) 1.20±0.14
1.18±1.12
(p=0.442)
1.18±0.14
(p=0.244)
1.17±0.15
(p=0.063)
1.14±0.07
(p=0.004)*
1.16±0.18
(p=0.043)*
CKI 
(-)
1.04±0.03 1.05±0.04(p=0.046)*
1.06±0.04
(p=0.129)
1.04±0.03
(p=0.131)
1.04±0.02
(p=0.024)*
1.04±0.02
(p=0.046)*
Rmin (mm) 6.25±0.64 6.34±0.73(p=0.969)
6.09±0.62
(p=0.778)
6.53±0.72
(p=0.008)*
6.38±0.61
(p=0.005)*
6.49±0.51
(p=0.028)*
IHA (µm) 70.84±58.36 61.45±42.8(p=0.239)
66.93±40.74
(p=0.161)
64.58±57.07
(p=0.260)
51.9±28.03
(p=0.005)*
65.45±67.75
(p=0.046)*
IHD (µm) 0.06±0.04 0.05±0.03(p=0.929)
0.07±0.03
(p=0.753)
0.05±0.05
(p=0.012)*
0.05±0.03
(p=0.002)*
0.06±0.04
(p=0.027)*
CKI: central keratoconus index, IHA: index of height asymmetry, IHD: index of height decentration, ISV: index of surface variance, IVA: index of vertical 
asymmetry, KI: keratoconus index, Rmin: minimum radius of curvature
* Statistically significant change from preoperative measurements (p<0.05)
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Discussion
Keratoconus is an ectasic disorder in which the central 
or paracentral cornea undergoes progressive thinning 
and bulging. As keratoconus progresses the cornea gets 
thinner and the bulging of the cornea leads to an increase 
in keratometric values. Corneal collagen cross-linking 
treatment arrests the progression of keratoconus (1–3, 
10) and the improvement can be monitored by keratom-
etry, CT and topography indices. Arbelaez et al. found a 
1.40 D decrease in maximum keratometry one year after 
cross-linking treatment for keratoconus when compared 
Figure 2. Change in topography indices over time after cross-linking. Index of surface variance (ISV), index of vertical 
asymmetry (IVA), keratoconus index (KI), central keratoconus index (CKI), minimum radius of curvature (Rmin), index of 
height asymmetry (IHA), index of height decentration (IHD).
with preoperative values. Also, they documented a de-
crease in average keratometry by a mean of 1.36 D (7). 
Table 4 demonstrates the changes in Kmax values in dif-
ferent studies up to date. In our study, Kmax values only 
showed a significant decrease at the 1st month visit but 
there wasn’t any significant change from baseline in other 
visits.
In the current study, preoperative mean CCT (485.23±34.19 
µm) was decreased to 442.67±38.29 µm and 442.50±47.44 
µm at postoperative 1st and 3rd month visits respectively. 
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At the following visits, an increase in CCT was observed 
and after 6 months the preoperative values were reached. 
A review of the literature about the corneal thickness 
changes after cross-linking for keratoconus is presented 
in the Table 4. Toprak et al. reported a significant decrease 
in corneal thickness between baseline and six months 
(11). Vinciguerra et al. reported that the decrease in cor-
neal thickness at 2, 4 and 6 mm were persistent after 1 
year, but they found no significant difference at 0 or 8 mm 
(12). Arbelaez et al. demonstrated corneal thinning and 
re-thickening process after cross-linking treatment (7). 
They found corneal thinning 3 months after the cross-link-
ing treatment but later a steady increase was observed. 
This is consistent with the apoptosis after cross-linking 
treatment (lasting 2–3 months) and the repopulation 
that occurs thereafter (6 months). And the current study 
is concordant with this apoptosis and repopulation seen 
after cross-linking.
Keratoconus leads to deterioration of corneal topo-
graphic indices from normal values. Topographic indices 
evaluated in this study are ISV, IVA, KI, CKI, Rmin, IHA, 
and IHD. ISV is the standard deviation of individual cor-
neal sagittal radii from the mean curvature. It is thus an 
expression of the corneal surface irregularity. It is unit-
less and elevated in all types of corneal surface irregu-
larities (e.g., scars, astigmatism, deformities caused by 
contact lenses). In this study preoperative high ISV val-
ues decreased significantly starting from the 6th month 
visit. IVA is the measure (expressed in mm) of the mean 
difference between superior and inferior corneal curva-
ture. It is thus the value of curvature symmetry, with re-
spect to the horizontal meridian as the axis of reflection. 
Again, we proved a significant decrease in IVA values 
starting from the 6th month visit. KI is a unitless index 
expressing the ratio between mean radius values in the 
upper and lower segment (r sagittal superior to r sagittal 
inferior). CKI is the ratio (unitless) between mean radius 
values in a peripheral ring divided by a central ring: r sag 
(mean peripheral) to r sag mean center. In this study KI 
and CKI values decreased significantly after 6th month 
visit. Rmin is a measurement (mm) of the smallest radius 
of sagittal corneal curvature (i.e., the maximum steep-
ness of the cone). The significant increase in Rmin is 
consistent with the decrease in Kmax after cross-linking 
treatment. We found a significant increase in Rmin val-
ues starting from 6th month. Although the decrease in 
Kmax in our study wasn’t significant except 1st month 
visit, significant decreases in Kmax values were shown 
in larger study groups in literature (5, 13, 14). IHA is sim-
ilar to the IVA but it is more sensitive because it is based 
on corneal elevation. It is the mean difference between 
height values superior minus height values inferior with 
horizontal meridian as mirror axis (expressed in μm). We 
found a significant decrease at 12th and 18th month visit 
in IHA values. IHD is the value of the decentration of el-
evation data in the vertical direction (expressed in μm), 
and is calculated from a Fourier analysis. This index pro-
vides the degree of decentration in the vertical direction, 
calculated on a ring with radius 3 mm. In this study a sig-
nificant decrease was observed starting from 6th month.
In a prospective study comprising 71 eyes (49 keratoco-
nus and 22 post-LASIK ectasia) Greenstein et al. found 
significant improvements in the index of surface variance, 
index of vertical asymmetry, keratoconus index, and min-
imum radius of curvature at 1 year compared with base-
line. But the results were significant only in the subgroup 
of keratoconus patients (6). In another retrospective study 
Richoz et al. evaluated 26 eyes with postoperative ectasia 
after LASIK and PRK with a mean follow-up of 25 months 
and found a significant increase in Rmin whereas a signifi-
cant decrease in index of surface variance, index of vertical 
asymmetry, keratoconus index and the central keratoco-
nus index (15). Table 5 gives the summary of the literature 
about corneal topography index changes after corneal 
collagen cross-linking for keratoconus. Kanellopoulos et 
al. demonstrated the correlation between keratoconus 
severity and progression indicators, and the anterior sur-
face topographic indices and found that ISV followed by 
IHD are the most sensitive and specific indices in the diag-
nosis, progression and surgical follow-up of keratoconus 
(16). In the studies presented above there were no signif-
icant changes in IHA and IHD values after cross-linking 
but in this study, we found a significant decrease of IHA at 
the 12th and 18th month visits and significant decrease of 
IHD after 6 months.
The major limitation of the present study is its small sam-
ple size, which limits extrapolation of the findings to the 
general population.
In conclusion, our study demonstrated the positive ef-
fect of cross-linking treatment on corneal thickness and 
topography indices starting from 6th month post-opera-
tively over 18 months. The pause in corneal thinning and 
steepening and a decrease in corneal topography indices 
(except Rmin) may suggest the pause and the reversal of 
the corneal distortion during keratoconus progression. 
Long-term effects of cross-linking treatment on corneal 
parameters should be investigated.
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Table 4. Literature summary for corneal collagen cross-linking in keratoconus: Keratometry and corneal thickness.
Mean (±SD/range)
Author Year Follow-upa (months) Number of eyesb K1, K2 CT1, CT2
Present Study 2014 18 15 48.42±4.5746.73±2.87
485.23±34.19
488.67±25.71
Wittig-Silva17 2014 36 46
↓ 0.72±0.15* 1st year
↓ 0.96±0.16* 2nd year
↓ 1.03±0.19* 3rd year
↓ 19.52±5.06*
Ghanem18 2014 24 42 54.2±4.253.3±4.1*
487±46
501±34
Toprak19 2014 12 96 54.54±5.5053.52±5.18*
460.11±47.15
430.65±61.90*
Goldich20 2014 36 17 53.90±5.9052.50±5.10
463±38
466±50
Sloot21 2013 12 53 58.6±7.9
57.3±7.1*
453±45
447±47
Toprak22 2013 12 59 53.83±4.43
52.67±4.33*
-
Poli23 2013 36 45 50.55±3.7550.36±3.60
450.00
444.00
Toprak11 2013 6 47 53.70±4.3152.80±4.38*
471.30±43.54
434.19±56.85*
Hashemi24 2013 60 40 49.37±3.4849.13±3.29
483.87±29.07
485.95±28.43
Viswanathan25 2012 48 51 49.65±4.9148.69±4.56*
470.35±39.26
467.64±43.54
Hassan8 2012 36 38 51.43±5.6050.98±6.43 No statistical change
Goldich26 2012 24 14 53.90±5.9051.50±5.40*
461±38
466±46
Asri27 2011 12 142 54.09±6.0753.60±5.47*
468±36
459±47
Koller28 2011 12 151 ↓ 1.0* in 57 
patients 
-
Hersh29 2011 12 49 60.4±9.9958.4±8.41* -
Greenstein30 2011 12 54 - 458.20±51.40450.00±52.50*
O’Brart31 2011 18 22 47.1646.86
483
487
Henriquez32 2011 12 10 ↓ 2.66* 471.5462.8
Caporossi13 2010 60 44 ↓ 2.0 450±14.54451
Coskunseven33 2009 12 38 54.02±4.1552.45±4.01*
457±21
446±26
Grewal34 2009 12 102 51.35±5.1150.15±5.39 No statistical change
Vinciguerra12 2009 24 28 53.5949.02*
490.68±30.69
479.91±32.21
Arbelaez7 2009 12 20 51.89±7.9950.49±8.35*
463.96±27.28
463.95±37.36
Vinciguerra14 2009 12 28 50.3744.21*
490.68±30.69
470.09±29.01*
Agrawal36 2009 12 37 53.26±5.93-2,47±3.89 change -
Raiskup-Wolf5 2008 72 241
↓ 1.46±3.76* 1st year
↓ 1.91±4.36* 2nd year
↓ 2.57±3.71* 3rd year 
-2±12 (1st year)
21±31* (2ndyear)
Wittig-Silva37 2008 12 33 ↓ 1.45±1.0* -
Caporossi4 2006 6 10 ↓ 1.9 431.5 (406-468)450.6 (416-480)
Wollensak1 2003 48 23 ↓ 2.01* in 16 eyesno change in 5 eyes -
a: maximum follow-up; b: treated eyes with keratoconus; 1: preoperative; 2: postoperative final. K: keratometry value, preferably Kmax; CT: corneal thickness, preferably central.  
*: statistically significant change from preoperative measurements (p<0.05)
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